Company: ABBV
Filing Date: 2025-03-24
Form Type: DEF 14A
Source: 0001558370-25-003537
Chunk: 39

Company: AbbVie Inc.
Filing Date: 2025-03-24
Form: DEF 14A
Chunk 39
---
 | ​ | 38.6 pts above index | ​  |    |
| Payout Modification                         | ​ | -25%               | ​ | 0%                         | ​ | +25%               | ​ | +25% Modification    | ​  | ​​ |

Policies and Practices Related to the Timing of Grants of Certain Equity Awards AbbVie’s policy with respect to its annual equity award for all eligible employees, including the NEOs, is to grant the award and set the grant price, which is used to calculate the number of shares covered by awards and establish the exercise price for stock options, at the compensation committee’s regularly scheduled February meeting each year. These meeting dates generally are the third Thursday of February and are scheduled two years in advance. The grant price is the average of the highest and lowest trading prices of a common share on the date of the grant (rounded up to the next even penny). The grant price for the 2024 annual grant was $175.28. The high, low and closing prices of an AbbVie common share on the grant date (February 15, 2024) were $176.74, $173.81, and $176.59 respectively. All LTI awards are subject to a minimum vesting period of 12 months. The company does notschedule its equity grantsin anticipation of the release of material, non-public information (“MNPI”) or time the release of MNPI based on equity grant dates. The following table presents information regarding option awards granted to our NEOs in the fiscal year ended December 31, 2024, during any period beginning four business days before the filing or furnishing of a periodic report or current report disclosing MNPI and ending one business day after the filing or furnishing of such report with the SEC.

46 | 2025 Proxy Statement

| ​ | ​                      |
| ​ | EXECUTIVE COMPENSATION |

| Name                  |     | Grant date |     |      Number of 
     securities 
 underlying the 
          award |     | Exercise     
 price of the 
 award        
 ($/Share)    |        |     | Grant date fair 
    value of the 
           award |     |      Percentage 
   change in the 
  closing market 
    price of the 
      securities 
  underlying the 
   award between 
 the trading day 
          ending 
     immediately 
    prior to the 
   disclosure of 
        material 
       nonpublic 
 information and 
 the trading day 
       beginning